International Internet Magazine. Baltic States news & analytics
Tuesday, 28.06.2016, 12:34
Lithuania's pharmaceutical wholesaler GlaxoSmithKline Lietuva is set to pay out 1.322 million euros as dividends to its sole shareholder after posting a net profit of 1.391 million euros for 2015, informs LETA/BNS.
Keyword tags: EU – Baltic States, Good for Business, Lithuania, Markets and Companies, Medicine
In addition to CEO of the North Estonia Medical Center (PERH), Tonis Allik, who resigned on June 15 the hospital's board has also limited the powers of PERH's IT director Marko Kilk and catering chief Anu Vahi who also stand suspected of embezzlement, informs LETA/BNS.
The Tallinn city government has initiated a procedure to prepare a detailed plan for the plots at Narva Road 129 and 129b and nearby areas where the city's new main hospital complex is about to be built, informs LETA/BNS.
The Estonian Health Insurance Fund in 2015 covered the medical costs of Estonians in other European Union member states in the amount of 8.5 million euros, informs LETA/BNS.
The Baltic venture capital investor Baltcap was given permission on June 16th to acquire through the holding company Dencap a 72% stake in the Estonian occupational health care company Qvalitas Arstikeskus, informs LETA/BNS.
Latvian Saeima today voted on Anda Caksa, the head of Children's Clinical University Hospital, as Latvia's next health minister, informs LETA.
Latvian pharmaceutical group Olainfarm generated EUR 44.14 million in turnover in the first five months of 2016, which is 1% more than during the same period in 2015, informs LETA, according to the financial statements submitted to the Nasdaq Riga stock exchange.